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1. Introduction 
Modern computational science is converging on complex problems in the general field of 
systems biology. There is now a credible possibility of modeling drug delivery vesicles 
(liposomes) and their properties with qualitative and quantitative insight coming from 
atomistic calculations. Understanding the formation of vesicles from phospholipids bilayers 
and their fluidity and permeability properties is the basis of a large number of applications 
in the domain of drug delivery, in particular release of the active species according to the 
pH or ionic concentration changes. Prediction of structural changes (phase transition in 
particular) of membranes by modification of one or several constituents or addition of 
external molecular species may have potential therapeutic applications. Understanding the 
basic principles of biomembranes (lipid bilayers) governing and mediating various 
biologically relevant processes on the microscopic level is one of the great challenges in 
biology (Singh 2011). Molecular dynamic (MD) simulations are well suited for detailed 
analysis of the interactions between lipid bilayers and various small molecules, including 
water, chemicals, co-enzymes, peptides, oligonucleotides and proteins, as evidenced by the 
extensive body of published literature. Density Functional Theory (DFT) methods and 
recent theoretical studies of the properties of phospholipid molecules, consistent QM/MM 
and MM methodologies as well as their counterparts as function of time, Born-Oppenheimer 
dynamics (BOMD) and molecular dynamics (MD) are applied to understand and predict the 
properties of liposomes in water, in particular, fluidity, and their evolution in the presence 
of ions and biological agents. This has subsequently been achieved through the 
Dipalmitoylphosphatidylcholine (DPPC) bilayer systems and its partitioning with an ether 
lipid drug. Hence, membrane-lipid therapy plays a dominant role in molecular medicine.   
1.1 Cellular model of lipid membranes and drug partitioning 
The model of the DPPC bilayer was used for simulation of the phospholipid environment 
around the drug. The lipid parameters were taken from the literature (Lipka et al., 1984). 
The partial atomic charges were calculated at DFT/B3LYP/6- 31G** level using Gaussian 09 
package. Also, the partitioning of large molecular systems was done by following ONIOM 
(Our-own-N-layered integrated molecular orbital and molecular mechanics) method, 
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whereby the whole system is partitioned into onion-skin-like layers, using QM/MM. The 
total energy can be obtained from following: 
E= E[Low, real] + E[Med, int] + E[High, inner]-  
E[Low,int]-E[Med, inner]  = E6+E5+E4-E3-E2 
 
High 
System Size 
Medium 
Low 
 inner intermediate real  
 
where real denotes the entire system, which is treated at low level, while int denotes the part 
of the system partitioned to be the intermediate layers for which the energy is calculated at 
both medium and high levels. Here inner denotes the inner layer of the system partitioning, 
whose energy is calculated at both high and medium levels. 
Chemical potential profile, μ(z), of solute across a lipid bilayer and adjacent water phase is 
obtained by  inserting the solute numerous times into randomly selected positions in the 
system obtained by MD simulation and calculating the interaction energy, E(z), between the 
inserted solute and all the molecules in the system. From <exp (−E(z)/RT)>t, where <…>t 
denotes the thermal average over insertions of solute with randomly chosen orientations 
into configurations of the system at depth z unperturbed by the solute, the excess chemical 
potential, μ(z), and thereby the free energy of transfer, ΔG(z), from bulk water to the bilayer 
interior at the depth z are obtained: G(z) =μ (z) – μ (water) 
= -RTln<e-E(z)/RT>/<e-E(water)/RT> 
This simulation may enable us to understand the thermodynamic interactions between the 
lipid and drug molecules, the role of electrostatics in such adducts, and the permeability of 
drug (Fig. 1A & 1B). Degree of penetration into the membrane interior obtained from 
computer simulations may also be useful in estimating the extent to which a drug or 
prodrug that is unstable in a given solution or biological fluid might be protected when 
bound to a lipid bilayer membrane (Fig.1B&C). Multi-scale modeling and simulation 
revealed that the interactions between the drug and membrane are both electrostatic and 
hydrophobic. Increasing the chain length and lipophilicity may strengthen the binding 
interactions and overcome the problem of drug resistance.  
-E5
-E4
-E2
-E3 +E6
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Fig. 1. A) Neutral and charged states of miltefosine 
   
B C 
Fig. 1. B) Model representing DPPC bilayer system, C) Miltefosine with the lipid bilayer 
system. 
2. Membrane permeability, lipid metabolism and multi-drug resistance  
in Leishmania major 
Membrane impermeability is the major contributing factor to multidrug resistance in clinical 
isolates of Leishmania major (Perez Victoria et al., 2006). Reductionism which dominated 
biological research for over a century has provided a wealth of information about individual 
cellular components and their functions. Understanding the structure and the dynamics of 
the complex intercellular web of interactions that contribute to the structure and function of 
a living cell is a key challenge for biology in the 21st century.  
The recent developments in genome sequencing (complete for L. major, L. braziliensis, and L. 
infantum) and lipidomic tools conceive a powerful platform for the study of lipid 
Miltefosine 
DPPC 
DPPC 
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metabolism in Leishmania. Lipid concentration changes in biological systems reflect 
regulation at multiple spatial and dynamic scales, e.g., biochemical reactions in the cells, 
intercellular lipid trafficking, changes in cell membrane composition, systemic lipid 
metabolism or lipid oxidation [Niemela et al., 2009]. Excluding the transport reactions, the 
percentage of intracellular reactions participating in lipid metabolism in L.major was the 
greatest, when compared to reactions across other metabolic subsystems [Chavali et al., 
2008].  In order to address the intricacies of lipid regulation, it is quite obligatory to analyze 
the lipid metabolic mechanisms (Fig.2). 
 
Fig. 2. Distribution of Metabolic Pathways according to the Cellular Processes. Neglecting 
the Transport Reactions, the Lipid Metabolism shows the highest no. of intracellular 
reactions signifying the abundance of the lipid biochemical networks. 
The L.major pathogen is decoded at the interactome level, and the study is converged into 
the Lipid Metabolic Pathway, to serve the purpose of targeting the probable ligand via 
Liposomal Drug Delivery. Lipids play an active role in a variety of dynamic processes 
involving the membranes that compartmentalize the cell. To achieve this, cell must 
regulate the mechanical properties of the membrane and it can do so partly by controlling 
its lipid composition. The underlying biophysical question is to understand the variability 
and chemical diversity of membrane lipid composition, the mechanical properties of the 
membrane and the associated protein functions. Lipid metabolism is essential to the 
development, multiplication, virulence and differentiation of Leishmania species in the 
host, thus making the pathways for synthesis of parasite lipids good targets for 
development of new anti-leishmanial drugs [Zufferey and Mamoun, 2005; Zhang K. et al., 
2003; Zufferey et al., 2003; Haughan et al.,1995]. Thereby, the diversity between 
Leishmania and mammals in lipid composition could be exploited towards selective 
chemotherapy. Lipids being a crucial entity of the pathogen cell surface are given 
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extensive importance and moreover due to the liposomal drug delivery system, targeting 
the lipids organized in the membrane of the pathogen would be an added advantage for 
the smooth release of the encapsulated drug.  
The cell surface of Leishmania spp. has been shown to play a role in host-pathogen 
interactions and in the ability of the pathogen to evade the host-immune system. LPGs are 
essential for adhesion of the parasite to the midgut of the insect and therefore are important 
for transmission of the parasite to the human host. The basic LPG structure in all 
Leishmania species consists of several domains like the GPI anchor, with an 1-O-alkyl-2-
lyso-phosphatidyl inositol lipid joined to a heptasaccharide glycan core, a long 
phosphoglycan (PG) domain composed of (Gal ǃ1-4manǂ1-PO4)n repeat units (n=15-30), 
and a small neutral oligosaccharide cap [Bergter and Vermelho, 2010]. In different 
Leishmania species the phosphoglycan repeat units contain additional substitutions that 
mediate key roles in stage-specific adhesion. Deletion of LPG in L.major indicates that the 
glycosylated structures are involved in resistance to oxidative stress and the human immune 
system [Oppenheimer et al., 2011]. Henceforth, it is evident that lipids are essential cell 
constituents and therefore must be constantly synthesized to allow multiplication of the 
parasite. This suggests that the pathways leading to their synthesis are essential for parasite 
proliferation and pathogenesis and thus offers a reasonable target for rational design of 
novel antileishmanial drugs. Galf plays an important role in host specific cell recognition, 
parasitic growth and pathogenesis. Since Galf is not present in humans, the Galf 
biosynthetic pathway is an attractive target for the development of novel anti-parasitic 
drugs. In this pathway, UDP-galactopyranose mutase (UGM) catalyzes the conversion of 
UDP-galactopyranose to form UPD-Galf, which serves as a precursor for all the Galf found 
on the cell surface. Deletion of UGM gene may lead to the identification of specific inhibitors 
of this enzyme. [Oppenheimer et al., 2011] 
Interactome Network Building is a crucial step for advancing towards Mathematical 
modeling, using the Systems Biology Markup Language. Metabolic network reconstruction 
has become an indispensable tool for studying the systems biology of metabolism. The focus 
is laid onto reviewing the mathematical foundations for analyzing chemical reactions, and 
describing how these systems of coupled chemical reactions can provide insight into the 
behavior of complex regulatory mechanisms. This is accomplished using the simulation 
mechanisms based on the certain defined kinetic laws such as Convenience Kinetics, 
Generalized Mass Action Kinetics and the Hill-Hinze equation. A saturable rate law 
“Convenience Kinetics” - a generalised form of Michaelis-Menten kinetics, covers all 
possible stoichiometries, describes enzyme regulation by activators and inhibitors, and can 
be derived from a rapid-equilibrium random-order enzyme mechanism. Convenience 
kinetics is used to translate a biochemical network – manually into a dynamical model with 
rational biological properties. It implements enzyme saturation and regulation by activators 
and inhibitors, covers all possible reaction stoichiometries, and can be specified by a small 
number of parameters. Their mathematical forms make it especially suitable for parameter 
assessment and optimisation. To ensure thermodynamic correctness, it is written in terms of 
thermodynamically independent parameters [Liebermeister and Klipp, 2006]. Moreover, the 
classes of generalized kinetic expressions of GMA also ensure consistency with the extended 
thermodynamic conditions [Horn and Jackson, 2004]. 
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Simulation can provide the ultimate detail concerning individual particle motions as a 
function of time [Karplus and McCammon, 2002]. Thus, they can be used to address specific 
questions about the properties of a model system, often more easily than experiments on the 
actual system. These techniques are carried out upon treating a biological process as a 
system of equations, represented by their rate constants and other parameters and 
simulating their interactions through numerical techniques. The numerical simulations 
capture the effects of genes and their expression level through the time-course of evolution 
at molecular concentration. Thus, it is a biochemical characterization of the enzymatic 
network using the systems biology approach by interconnecting mathematical, biological, 
and physical sciences with the aim to capture the behavioural sciences of the enzymes, in 
the temporal and spatial scales, eventually leading to the discrete stochastic kinetic 
simulation. The integration of genomic and physiological information is now increasingly 
important with the emergence of “systems biology‟, which attempts to simultaneously 
study the expression patterns and activity of all genes, together with proteomic and 
metabolomic data [Cavalieri and Filippo, 2005]. When combined with a specific method of 
analysis like flux balance analysis (FBA), constraint-based models can be used to generate 
quantitative predictions (e.g., growth rate of an organism) and yield testable hypotheses for 
future experimental investigations [Roberts et al., 2009; Lee et al., 2006]. This permits an 
iterative process of model development, hypothesis generation and testing, and further 
model development and refinement [Reed et al., 2006]. Hence, looking at the disease as 
“perturbation of networks‟ can provide such a framework which may offer insights from 
systems biology into the practicalities of personalized, preventive, predictive and 
participative (P4) medicine [Antonio del Sol et al., 2010]. Using this approach, a base is 
formulated for the appropriate selection of an inhibitor, taking into account the dynamics of 
the enzyme kinetics. 
2.1 Lipophosphoglycan & GIPL structure 
The parasite surface is the primary interface of Leishmania with the host, and is comprised 
largely of three abundant classes of glycosylphosphatidylinositol (GPI)-anchored molecules: 
lipophosphoglycan (LPG), a smaller heterogeneous group of glycoinositolphospholipids 
(GIPLs), and proteins such as gp63, gp46, PSA-2, and proteophosphoglycans (PPGs) [G.F. 
Spath, 2000]. This LPG is held together with a phosphoinositide membrane anchor, and has 
a tripartite structure consisting of a lipid domain, a neutral hexasaccharide, and a 
phosphorylated galactose-mannose, with a termination in a neutral cap [G.F. Spath, 2000] 
(Fig.3). LPG is in abundance in the cell membrane and is extended from the cell surface. In 
the mammalian host, LPG confers resistance to complement-mediated lysis, oxidative stress, 
and inhibits phagolysosomal fusion. In Leishmania major, the core of the abundant  
surface lipophosphoglycan (LPG) is structurally related to that of the smaller 
glycosylinositolphospholipids (GIPLs) in containing galactosylfuranose (Galf) residues in a 
Gal0–2Galf (ǃ3)Man motif [Zhang et al., 2004]. However, deletion of the putative Galf -
transferase (Galf T) LPG1 affected Galf incorporation in LPG but not GIPLs [G.F. Spath, 
2000]. Thus, LPG and LPG1 satisfy the requirements for virulence factors genes as set forth 
by the modern ‘‘Molecular Koch’s postulates’’, establishing LPG itself as a Leishmania 
virulence factor [Falkow S, 1988]. 
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Fig. 3. Structure of GIPLs and LPGs in L. major. 
2.2 Stochastic simulation  
The study of metabolic networks is of high relevance, because of their implications for the 
basic understanding of living cells and organisms and for medical applications, especially 
with respect to discovering drug targets [Pavlopoulos et al., 2008]. Defining a system by the 
dynamic state of its metabolome relies on the effective integration of omics data because the 
metabolic state of the system is largely derived from the global expression of its genome and 
proteome [Davidov et al., 2003]. Recent advances enable the production of metabolic 
network models reconstructed from genome sequences, as well as experimental 
measurements of much of the metabolome [Douglas B. Kell, 2006]. The network-based 
representation and analysis of biological systems contributes to a greater understanding of 
their structures and functions at different levels of complexity. These techniques can also be 
used to identify potential novel therapeutic targets based on the characterisation of 
vulnerable or highly influential network components [Azuaje et al., 2010]. Recently 
developed computational tools enable rational and graphical composition of genetic circuits 
for standard parts, and subsequent simulation for testing the predicted functions in silico 
[Marchisio and Stelling, 2009]. Model construction typically involves the translation of prior 
knowledge into a list of reactants and reactions [Aldridge et al., 2006]. These models require 
information about the kinetics of each of the reactions participating in the network, such as 
the kinetic laws describing the dynamics of the reactions with their respective parameters. 
Thereafter, kinetic equations are mapped to the reaction model through either stochastic or 
deterministic approaches, and at times a hybrid model may be adopted. Several modelling 
approaches are derived from assuming different simplistic kinetic mechanisms: 
Convenience rate law, mass-action, Michaelis-Menten, power-law, LinLog [Sergio Grimbs, 
2009]. There are several modes of modeling these metabolic networks: Structural modeling, 
Flux balance Analysis and Metabolic control Analysis. Thus, using the concept of 
mathematical modeling and applying the science of systems biology, the simulation of 
metabolic pathway is carried out based on certain kinetic laws and their parameters. 
Once a target is identified, whole cell screening assays can be designed, using synthetic 
biology strategies [Weber and Fusseneger, 2009]. Temporal information from computer 
simulations are validated by those done on simplified versions of yeast cell cycle and have 
shown to be in good agreement with experiment [Tyson et al., 2001]. The conversion of a 
reconstruction into a mathematical format facilitates a myriad of computational biological 
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studies, including evaluation of network content, hypothesis testing and generation, analysis 
of phenotypic characteristics and metabolic engineering [Thiele and Bernhard , 2010].  
2.3 Enzymes unique to L.major and absent in H.sapiens 
It was noted that these distinctive enzymes listed below restricted only to L.major catalyzed 
reactions are involved in some of the metabolic pathways (Table 1). 
Sr. No. Enzymes 
Metabolic 
Pathways 
1 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 7 
LPG,GIPL,GPI  
Biosynthetic 
Pathway 
2 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 6 
3 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 5 
4 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 4 
5 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 3 
6 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 2 
7 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase 1 
8 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 6 
9 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 5 
10 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 4 
11 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 3 
12 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 2 
13 side-chain/ phosphoglycan ǃ-1,3 galactosyltransferase related protein 1 
14 phosphoglycan ǃ-1,2 arabinosyltransferase 
15 side- chain ǃ-1,2 arabinosyltransferase 
16 mannosyltransferase (GPI14) 
17 GIPL galf transferase 
18 ǃ- galactofuranosyltransferase like protein (LPG1 ) 
19 galactofuranosyltransferase like protein lpg1 - like protein 
20 ǃ- galactofuranosyltransferase 
21 GPI 18/ PIG V 
22 GPI 10/ GPI anchor biosynthetic protein 
23 gpi transamidase complex 
24 Sterol C-24 reductase,putative 
Ergosterol 
Biosynthesis 
25 C-5 sterol desaturase,putative 
26 Sterol 24-C methyltransferase 
27 ∆6 desaturase 
Fatty Acid 
Elongation 
28 ∆4 desaturase 
29 ∆6 elongase 
30 ∆5 elongase 
31 ∆5 desaturase 
32 ∆12 desaturase 
33 stearic acid desaturase 
34 enoyl-[-ACP] reductase, putative 
35 fatty acid elongase Fatty Acid 
Biosynthesis 36 ǃ- ketoacyl ACP synthase 
37 cardiolipin synthase, putative 
Ester 
Biosynthesis 
Table 1. Enzymes restricted to L.major and the respective Metabolic Pathways belonging to 
Lipid and Fatty Acid Biochemical Network. 
www.intechopen.com
 
Stochastic Simulation for Biochemical Reaction Networks in Infectious Disease 
 
337 
Thus, of the overall 20 metabolic pathways involved in Lipid and Fatty Acid Metabolism, 
there are 13 such pathways which are exclusively restricted to L.major, of which only 7 
pathways had the enzymes and reactions unique to L.major. From the Table 1 it is found that 
the maximum number of the genes and the resultant gene products (enzymes), distinctive to 
the L.major are specifically engaged in the LPG and GIPL Biosynthesis Pathway followed by 
the fatty acid metabolism.  
2.4 Gene Regulatory Network (GRN) and lipid metabolism  
The prior mentioned metabolic pathways (Fig.4) are taken into account to form an 
interacting regulatory network of genes in order to lay an emphasis upon the clustering of 
the genes into metabolic pathways of related functions. 
 
Fig. 4. Pie chart showing the abundance of unique enzymes present in LPG, GPI anchor and 
GIPL biosynthetic pathway. 
A gene regulatory network (GRN) aims to capture the dependencies between these 
molecular entities and is often modeled as a network composed of nodes which represents 
genes, proteins and/or metabolites) and edges representing molecular interactions such as 
protein–DNA and protein–protein interactions or rather indirect relationships between 
genes. Network model architectures can be distinguished by the type of model: stochastic or 
deterministic, static or dynamic and the type of relationships between the variables (directed 
or undirected; linear or non-linear function or relation table). Although many undirected 
network representations exist, the focus of this chapter is on directed networks. 
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From this network it is clearly visible, that LPG Biosynthetic Pathway, GIPL Biosynthesis 
Pathway, GPI anchor Biosynthesis Pathway, and Dolichyl-diphosphooligosaccharide 
biosynthesis Pathway are inter-connected through one or more genes involved commonly in 
the regulation of the proteins which act as enzymes catalyzing the reactions in these 
pathways (Fig.5). 
 
Fig. 5. Gene Regulatory Network constructed using Cytoscape for visualizing the inter-
connection of the Lipid  Metabolic Pathways restricted to L.major *. 
*Legend overleaf 
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Similarly, the pathways Fatty Acid Elongation (Saturated and Unsaturated), Fatty acid 
biosynthesis Initiation, Very Light Chain Fatty Acid Biosynthesis and Fatty acid 
biosynthesis-elongase pathway; and the pathways Ester phospholipid biosynthesis, 
Sphingolipid Metabolism and Glycerolipid biosynthesis- initial steps are respectively inter-
related through common intervention of the genes. But, the pathways Ergosterol 
Biosynthesis and Ether Phospholipid Biosynthesis are the only ones that are not related with 
any of the other Metabolic Reactions, and are self-contained. 
Hence, the gene regulatory network gives an entire overview about the reacting species in 
the same dimension.  The reactions and pathways that are inter-connected and have 
common enzymes and compounds taking part in the same reactions can further be 
investigated. Also, it gives an outline and a general idea related to the cluster of genes 
taking part in the reactions. 
From the Cytoscape Regulatory Network of the Lipid Metabolism Pathway, it is found that 
the maximum number of the genes and the resultant gene products (enzymes), distinctive to 
the L.major, ae specifically clustered in the LPG and GIPL Biosynthesis Pathway, followed 
by the fatty acid metabolism.  
Thereby, from the Cytoscape network and Fig 6, it is established that majority of the 
enzymes in a large number are present only in the LPG, GIPL and GPI  anchor bioynthesis 
pathways, thus giving a wide scope for the enzymatic studies to be undertaken. 
Consequently, the Lipophosphoglycan Pathway in conjunction with the GIPL and GPI 
anchor biosynthesis is of paramount importance.  
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Fig. 6. Enlarged portion of the Gene Regulatory Network focusing on the large number of 
genes involved in LPG, GIPl and GPI anchor biosynthesis pathway [Pathways marked by 
red octagon]. Thus it can be concluded that the gene GPI 14 [marked by off-white] can play 
a crucial role in the pathway since it is at a junction leading to the other 2 pathways- GIPL 
and GPI. Also, the cluster of genes assembled into Group1 [marked by pink] is at a vital 
cross-road leading to GIPL and LPG Biosynthetic Pathway.  
2.5 Compartmentalization 
The sub-cellular localization of the target enzymes plays a very significant role in order to 
introduce an inhibitor in a cellular system. Hence, the location of the enzymes involved in 
LPG Biosynthetic Pathway is determined and the presence of the transmembrane domains 
is also checked (Table 2). 
Cellular overview was created using this data to simplify the complexity and for elaborative 
interpretation of the data.  The compartments included are Nucleus, Golgi apparatus, 
Endoplasmic Reticulum, and the Cell Membrane. The fluxes and the choke-point reactions 
are also marked to indicate the critical reactions in the pathway (Fig.7). 
 
Sub-cellular Localization of enzymes involved in the  LPG Metabolic Pathway 
Sr. 
No. 
Enzymes 
TMHMM 
domains 
Sub-cellular 
Localization 
Signal 
Peptide 
Signal 
Anchor 
1 
phosphatidylinositol-N-acetylglucos-
aminyltransferase subunit c, putative 7 
integral to  Cell 
membrane - - 
2 
n-acetylglucosaminyl-phosphatidyl 
inositol biosynthetic protein,putative - cytoplasm - - 
3 
N-acetyl-D-glucosaminyl-
phosphatidylinositol deacetylase 1 
integral to cell 
membrane Present - 
4 mannosyl transferase,putative 8 integral to ER - - 
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Sub-cellular Localization of enzymes involved in the  LPG Metabolic Pathway 
Sr. 
No. 
Enzymes 
TMHMM 
domains 
Sub-cellular 
Localization 
Signal 
Peptide 
Signal 
Anchor 
membrane 
5 
beta galactofuranosyl transferase  
1 
integral to cell 
membrane - Present 
6 
GIPL galf transferase, putative 
1 
integral to cell 
membrane Present - 
7 
beta-galactofuranosyltransferase-like 
protein 1 
integral to cell 
membrane - Present 
8 
galactofuranosyltransferase lpg1-like 
protein 1 
integral to cell 
membrane - Present 
9 
GIPL galf transferase, putative  
1 
integral to cell 
membrane - Present 
10 GIPL galf transferase, putative  - cytoplasm - - 
11 
phosphoglycan beta 1,3 
galactosyltransferase 4, scβGalT 1 Golgi Membrane Present - 
12 
phosphoglycan beta 1,3 
galactosyltransferase 3, scβGalT 1 Golgi Membrane - - 
13 
phosphoglycan beta 1,3 
galactosyltransferase 2, scβGalT 1 Golgi Membrane - - 
14 
phosphoglycan beta 1,3 
galactosyltransferase 1, scβGalT  1 Golgi Membrane - - 
15 
side chain β1,3 galactosyltransferase-like 
protein 1 Golgi Membrane - - 
16 
side chain β1,3 galactosyltransferase-
related protein 6  1 Golgi Membrane - - 
17 
side chain β1,3 galactosyltransferase-
related protein 5 1 Golgi Membrane - - 
18 
side chain β1,3 galactosyltransferase-
related protein 4 1 Golgi Membrane - - 
19 
side chain β1,3 galactosyltransferase-
related protein 3 1 Golgi Membrane - Present 
20 
side chain β1,3 galactosyltransferase-
related protein 2 1 Golgi Membrane - - 
21 
side chain β1,3 galactosyltransferase-
related protein 1 1 Golgi Membrane - - 
22 
phosphoglycan beta 1,3 
galactosyltransferase 7, scβGalT  1 Golgi Membrane - - 
23 
phosphoglycan beta 1,3 
galactosyltransferase 6, scβGalT  1 Golgi Membrane - - 
24 
phosphoglycan beta 1,3 
galactosyltransferase 5, scβGalT  1 Golgi Membrane - - 
25 
phosphoglycan beta 1,2 
arabinosyltransferase, scβAraT-2 1 Golgi Lumen - - 
26 
phosphoglycan beta 1,2 
arabinosyltransferase, scβAraT  1 Golgi Lumen - - 
27 
phosphoglycan beta 1,2 
arabinosyltransferase 1 Golgi Lumen - - 
 
Table 2.  Sub-cellular Localization of the Enzymes, through Literature Survey, GeneDB and 
UniProtKB. The enzyme names marked in bold and italicized are the ones that are present 
exclusively in the L.major pathogen.  
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Fig. 7. Cellular Overview of the LPG Biosynthetic Pathway with respect to the Sub-cellular 
Localization, constructed using Cell Designer. The enzymes, for which the literature data 
was also not available, were considered to be within the cytosol.*   
www.intechopen.com
 
Stochastic Simulation for Biochemical Reaction Networks in Infectious Disease 
 
343 
* Legend overleaf 
 
2.6 Biochemical modeling  
Since it’s established that the Lipophosphoglycan Biosynthetic Pathway posed a vital role 
in the Leishmania Parasite, and is a significant Pathway for identifying the drug targets, it is 
reconstructed in Cell Designer for generating a Mathematical Model of the same (Fig.8). 
The genes coding for the enzymatic proteins, substrates, products, Enzyme-substrate 
complex, and the metabolites – all the entities are taken into account during the rebuilding 
of the pathway. 
From this reconstruction, an outline of the change in the fluxes through the pathway is 
created. The fact file of all the contributing moieties is described in Table 3 and Table 4. 
LPG Biosynthesis Reaction Summary 
Sr. No. Species Figures 
1 Enzymes 27 
2 Genes  27 
3 Metabolites 27 
 Consumed 13 
 Produced 14 
4 Compounds (Reactants & Products) 14 
5 Enzyme-Substrate Complexes 6 
6 Total no of Reactions 13 
 Enzyme Catalyzed Reactions 6 
 Non- Enzyme Catalyzed Reactions 7 
Table 3. Summary of the LPG Biosynthesis Reaction. 
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Fig. 8. Mathematical modeling of LPG Biosynthetic Pathway using Cell Designer. 
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Breakdown of Reactions 
1 Total no of Irreversible Reactions 67 
 Enzyme Catalyzed Reactions 54 
 Non- Enzyme Catalyzed Reactions 13 
2 Transport Reactions 51 
 Gene Reactions 27 
 Non-gene reactions 24 
3 
Non- Transport Reactions 
16 
Table 4. Analysis of the individual reactions occurring in the LPG Biosynthesis Pathway. 
Translating a known metabolic network into a dynamic model requires rate laws for all 
chemical reactions. The mathematical expressions depend on the underlying enzymatic 
mechanism; they can become quite involved and may contain a large number of parameters. 
Rate laws and enzyme parameters are still unknown for most enzymes. Convenience 
kinetics is used to translate a biochemical network – manually into a dynamical model with 
plausible biological properties. It implements enzyme saturation and regulation by 
activators and inhibitors, covers all possible reaction stoichiometries, and can be specified by 
a small number of parameters. Its mathematical form makes it especially suitable for 
parameter estimation and optimization. In general, the convenience kinetics applies to 
arbitrary reaction stoichiometries and captures biologically relevant behavior such as 
saturation, activation, inhibition with a small number of free parameters. It represents a 
simple molecular reaction mechanism in which substrates bind rapidly and in random order 
to the enzyme.  
2.6.1 Convenience mass action kinetics 
For the enzyme catalyzed reaction, i.e. from substrate to the ES-complex formation, the 
convenience rate law is taken into account. Rate laws and enzyme parameters are still 
unknown for most enzymes. For reactions with two or more catalysts, one individual rate 
law is generated for each catalyst. The total rate law for this particular reaction is given as 
the sum of the individual rates of all participating catalysts. The equation used here for 
convenience kinetics is:  
 
R M
kcat _ re
default default
E kcm _ re _ R kmc _ re _ M
R Mdefult 1 1
default default
kcm _ re _ R kmc _ re _ M
 

  
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where, E is the Enzyme concentration, kcat_re is the catalysis constant, R is the Reactant 
concentration, M is the Metabolite constant, kmc_re_R and kmc_re_M are the reactant and 
metabolite Michelis constants respectively, default indicates the default initial quantity 
value defined by us. For reactions with more than 1 enzyme (catalysts), the equation is 
summed up for each value of the enzymes.  
In general, the convenience kinetics applies to arbitrary reaction stoichiometries and 
captures biologically relevant behavior such as saturation, activation, inhibition with a small 
number of free parameters. It represents a simple molecular reaction mechanism in which 
substrates bind rapidly and in random order to the enzyme.  
2.6.2 Generalized mass action  
For non-enzyme catalyzed reaction, i.e. from the ES to the product formation, generalised 
mass-action kinetics is used. Mass action kinetics has numerous analytical properties that 
are of inherent interest from a dynamical systems perspective. These kinetic laws fail to 
describe enzyme saturation at high substrate concentrations, which is a common and 
relevant phenomenon. 
ES Co,plex
kass _ re
default
  
where, kass_re is the association constant, ES-complex is the concentration of the ES-
complex, default is the initial quantity value defined by us. 
2.6.3 Hill-Hinze equation 
SBMLsqueezer offers the general Hill equation as a kinetic law for the formation of gene 
products: 
 
hic _ re2 _ s2
re2 hic _ re2 _ 2 hic _ re2 _ s2
[R1]
V vmax_ re2
[R1] ksp _ re2 _ s2
    
Since it is assumed that the transition from a gene to protein as “a known transition 
omitted”, and ignored the RNA, the Hill equation is modified by the SBML Squeezer as per 
the reaction‟s convenience and the equation is given as: Vmax_re where, vmax is the 
maximum velocity attained. Now, according to Quassi Steady State rule, d/dt [mRNA] =0 , 
i.e. for the intermediate compound, and moreover the concentration of the mRNA reaches 
steady state very quickly, compared to protein concentration, it is considered that [mRNA] 
concentration is always considered at steady state. 
2.7 Numerical simulations  
On the basis of these kinetic laws, the numerical simulations are carried out with certain 
default values of the parameters and the initial quantities. By means of the numerical 
simulations, certain graphs are obtained which display the interactions of the molecules 
with each other and the effect of minute variations in the kinetic parameters. The graphs 
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also generate visualization for the fluxes. For each of the enzyme catalyzed reactions the 
simulation process is carried out separately for reducing the complications in interpretation 
of the graphs generated.  
In each of the graphs, it is postulated that there was a constant decrease in the concentration 
of the substrate, while the product had a steady increase in the concentration, with the ES 
complex initially forming up but then gradually decreasing with time when the product 
formation began each time. Therefore, on an overall basis, from the above generated graphs, 
it is concluded that as and when the downstream reaction is considered, there is a potential 
fall in the flux, though not in the reaction 1, indicating that the flux increased from reaction 1 
to reaction 2. Moreover, there is a consistent drop in the concentration of the ES complex as 
well, which signified that the product is gradually being formed. The concentration of gene 
G1 almost remain unchanged during this process as the transcription does not change the 
state of the gene. The principal result of this work is laid onto the idea that it shows a simply 
identifiable class of kinetic expressions, including the familiar detailed balanced kinetics as a 
proper subclass, which ensures consistency with the extended thermodynamic conditions. 
The rate laws applied provided a very good fit to the data. With the network model it is 
identified which steps have strong effect on other parts of the network using sensitivity 
analysis, and those steps that do indeed have high levels of control are then chosen further 
for kinetic analysis. This helped to further postulate that GPI 14 (encoding for 
mannosyltransferase) and Galf (encoding for Galf transferase) could be examined further 
since they showed a strong effect on the rest of the network model (Fig.9 A,B,C,D,E and F). 
The most important feature for building a bottom-up biochemical network model is that the 
relation between the concentration of the effectors and the rate be accurate. The objective is 
to learn more about how cells work via the means of computational models and not all 
about the mechanisms of catalysis, except when they are found themselves of importance to 
cellular function. The concept of "gene function" becomes synonym with the kinetics of its 
protein product embedded in the cellular biochemical network. 
The network-based representation and analysis of biological systems contributes to a greater 
understanding of their structures and functions at different levels of complexity. By defining 
the properties of a system as a whole, the approach aids in improvising decision making in 
the therapeutic drug development, which has a limitation otherwise, to be predicted from 
the parts. The goal of modeling in systems biology is to provide a background for 
hypothesis formulation and prediction based on in silico simulation of parasite biology 
across the multiple distance and time scales. The metabolic reconstruction of biochemical 
pathway serves as a tool for clarifying inconsistencies between data sources, and provides a 
platform for data integration and hypothesis generation for further scientific research in 
infectious disease. By means of the Cell Designer, utilizing its SBML language platform, we 
articulate a succinct representation of the biochemical properties adopted by a biological 
system and the underlying metabolic networks, and consequently translate them into 
systems compatible to stochastic simulations. Ensuing such model construction, and 
subsequent simulations we introduce a time component in the interaction reactions to 
determine certain physiochemical conditions of the biological system. Simulations aid in 
transforming the static data into the dynamic sphere of physiological timescales, by 
revealing insights into the flexibility of energy metabolism. These simulated models of  
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Fig. 9. Fluxes across six set of reactions in LPG biosynthetic pathway of L. major predicted 
through discrete stochastic simulation event. 
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biochemical reaction pathways are quite enthralling since their mathematics provides a 
means to amalgamate prior knowledge with postulated data and the underlying physical 
principles, through the graphical visualizations. Thus, we say graphical approaches simplify 
the process of transforming a network diagram into a set of linked equations. [Aldridge et 
al., 2006] Thereby, the prediction of potential novel targets can aid in the identification of 
revolutionary approach for controlling the level of specific, therapeutically relevant genes or 
proteins. We can test the efficacy of drug targets in the presence of enzyme inhibitors, 
through the metabolic reconstructions. These techniques can also be used to identify 
potential novel therapeutic targets based on the characterization of vulnerable or highly 
influential network components. [Azuaje et al., 2010] To summarize in a nutshell, the in vivo 
and in silico understanding of the ”Omics” field and the subsequent assimilation of genome, 
proteome, metabolome and interactome sciences in cellular and multicellular systems is 
essential for drug discovery.  
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